{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T00:15:29Z","timestamp":1783728929776,"version":"3.55.0"},"reference-count":45,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"29","license":[{"start":{"date-parts":[[2023,7,21]],"date-time":"2023-07-21T00:00:00Z","timestamp":1689897600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,7,21]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Postoperative nausea and vomiting (PONV) is one of the common adverse reactions after surgery. Recent randomized controlled trials (RCTs) investigating antiemetic drugs suggest that aprepitant has the strongest antiemetic effect of any single drug. This meta-analysis aimed to explore the efficacy of aprepitant for preventing PONV based on the existing literature.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>To identify RCTs investigating the use of aprepitant for PONV prevention, we searched PubMed, Embase, and Cochrane Library databases for articles published prior to March 20, 2022. Seventeen RCTs were identified, with 3299 patients, meeting the inclusion criteria. PONV incidence, complete response, 80\u2009mg aprepitant combined with dexamethasone and ondansetron, vomiting, nausea, and analgesic dose-response were the main outcomes measured.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Compared with the control group, PONV incidence was significantly reduced among those receiving aprepitant (odds ratio [OR]: 0.34; 95% confidence interval [CI]: 0.26, 0.44;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; .0001), with a more complete response (OR: 1.35; 95% CI: 1.14, 1.59;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = .0004). Supplementation of 80\u2009mg aprepitant in combination with dexamethasone and ondansetron substantially improved the effects of PONV (OR: 0.36; 95% CI: 0.16, 0.82;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = .01). Further, administration of 80\u2009mg aprepitant was better at preventing vomiting than nausea (OR: 8.6; 95% CI: 3.84, 19. 29;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; .00001). No statistically significant difference between the dose-response of analgesics was identified (mean difference: \u22121.09; 95% CI: \u22126.48, 4.30;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = .69). The risk of bias was assessed independently by paired evaluators.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Aprepitant effectively reduces the incidence of PONV; however, the effects of postoperative analgesia require further exploration.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000034385","type":"journal-article","created":{"date-parts":[[2023,7,21]],"date-time":"2023-07-21T14:43:27Z","timestamp":1689950607000},"page":"e34385","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":19,"title":["The efficacy of aprepitant for the prevention of postoperative nausea and vomiting: A meta-analysis"],"prefix":"10.1097","volume":"102","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-7177-1771","authenticated-orcid":false,"given":"Yingchao","family":"Liu","sequence":"first","affiliation":[{"name":"Department of Anesthesiology, the Second Affiliated Hospital of Fujian Medical University, Quanzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinli","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, the Second Affiliated Hospital of Fujian Medical University, Quanzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohua","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, the Second Affiliated Hospital of Fujian Medical University, Quanzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huohu","family":"Zhong","sequence":"additional","affiliation":[{"name":"Department of Ultrasound, the Second Affiliated Hospital of Fujian Medical University, Quanzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hefan","family":"He","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, the Second Affiliated Hospital of Fujian Medical University, Quanzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yibin","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, the Second Affiliated Hospital of Fujian Medical University, Quanzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuewen","family":"Liao","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, the Second Affiliated Hospital of Fujian Medical University, Quanzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhigang","family":"Pan","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, the Second Affiliated Hospital, Fujian Medical University, Quanzhou, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weipeng","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, the Second Affiliated Hospital, Fujian Medical University, Quanzhou, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weifeng","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, the Second Affiliated Hospital of Fujian Medical University, Quanzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4428-4450","authenticated-orcid":false,"given":"Feng","family":"Zheng","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, the Second Affiliated Hospital, Fujian Medical University, Quanzhou, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260710","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1097\/ACO.0000000000001063","article-title":"Management of postoperative nausea and vomiting in adults: current controversies.","volume":"34","author":"Rajan","year":"2021","journal-title":"Curr Opin Anaesthesiol"},{"key":"R2-20260710","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1007\/s40265-021-01532-y","article-title":"Neurokinin-1 antagonists for postoperative nausea and vomiting.","volume":"81","author":"Jin","year":"2021","journal-title":"Drugs"},{"key":"R3-20260710","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1213\/ANE.0000000000004833","article-title":"Fourth consensus guidelines for the management of postoperative nausea and vomiting.","volume":"131","author":"Gan","year":"2020","journal-title":"Anesth Analg"},{"key":"R4-20260710","doi-asserted-by":"crossref","first-page":"289","DOI":"10.4103\/ija.IJA_724_18","article-title":"Comparing the efficacy of aprepitant and ondansetron for the prevention of postoperative nausea and vomiting (PONV): a double blinded, randomised control trial in patients undergoing breast and thyroid surgeries.","volume":"63","author":"Jeyabalan","year":"2019","journal-title":"Indian J Anaesth"},{"key":"R5-20260710","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.bpa.2018.06.005","article-title":"What is new in the battle against postoperative nausea and vomiting?","volume":"32","author":"Tateosian","year":"2018","journal-title":"Best Pract Res Clin Anaesthesiol"},{"key":"R6-20260710","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1097\/SLA.0000000000002079","article-title":"Prevalence and risk factors for bariatric surgery readmissions: findings from 130,007 admissions in the metabolic and bariatric surgery accreditation and quality improvement program.","volume":"267","author":"Berger","year":"2018","journal-title":"Ann Surg"},{"key":"R7-20260710","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1097\/00000542-199909000-00022","article-title":"A simplified risk score for predicting postoperative nausea and vomiting: conclusions from cross-validations between two centers.","volume":"91","author":"Apfel","year":"1999","journal-title":"Anesthesiology"},{"key":"R8-20260710","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1097\/EJA.0b013e32834a4e1e","article-title":"Possibilities and limitations in the pharmacological management of postoperative nausea and vomiting.","volume":"28","author":"Kranke","year":"2011","journal-title":"Eur J Anaesthesiol"},{"key":"R9-20260710","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1097\/EJA.0000000000000242","article-title":"Aprepitant for antiemesis after laparoscopic gynaecological surgery: a randomised controlled trial.","volume":"33","author":"Ham","year":"2016","journal-title":"Eur J Anaesthesiol"},{"key":"R10-20260710","doi-asserted-by":"crossref","first-page":"e241132","DOI":"10.1136\/bcr-2020-241132","article-title":"Highly effective use of aprepitant in an adolescent girl with severe cyclic vomiting syndrome.","volume":"14","author":"Nivatsi","year":"2021","journal-title":"BMJ Case Rep"},{"key":"R11-20260710","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1111\/anae.15295","article-title":"Drugs for preventing postoperative nausea and vomiting in adults after general anaesthesia: an abridged Cochrane network meta-analysis.","volume":"76","author":"Weibel","year":"2021","journal-title":"Anaesthesia"},{"key":"R12-20260710","doi-asserted-by":"crossref","first-page":"440","DOI":"10.4097\/kja.d.18.00011","article-title":"Aprepitant in combination with palonosetron for the prevention of postoperative nausea and vomiting in female patients using intravenous patient-controlled analgesia.","volume":"71","author":"Yoo","year":"2018","journal-title":"Korean J Anesthesiol"},{"key":"R13-20260710","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/aas.13064","article-title":"Aprepitant as a fourth antiemetic prophylactic strategy in high-risk patients: a double-blind, randomized trial.","volume":"62","author":"de Morais","year":"2018","journal-title":"Acta Anaesthesiol Scand"},{"key":"R14-20260710","doi-asserted-by":"crossref","first-page":"e1688","DOI":"10.6061\/clinics\/2020\/e1688","article-title":"Aprepitant plus palonosetron for the prevention of postoperative nausea and vomiting after breast cancer surgery: a double blind, randomized trial.","volume":"75","author":"Grigio","year":"2020","journal-title":"Clinics (Sao Paulo)"},{"key":"R15-20260710","doi-asserted-by":"crossref","first-page":"4250","DOI":"10.1007\/s11695-020-04795-8","article-title":"A comprehensive approach for the prevention of nausea and vomiting following sleeve gastrectomy: a randomized controlled trial.","volume":"30","author":"Spaniolas","year":"2020","journal-title":"Obes Surg"},{"key":"R16-20260710","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jclinepi.2009.06.006","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration.","volume":"62","author":"Liberati","year":"2009","journal-title":"J Clin Epidemiol"},{"key":"R17-20260710","first-page":"ED000142","article-title":"Updated guidance for trusted systematic reviews: a new edition of the cochrane handbook for systematic reviews of interventions.","volume":"10","author":"Cumpston","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"R18-20260710","doi-asserted-by":"crossref","first-page":"465","DOI":"10.4103\/ija.IJA_119_21","article-title":"Effect of combinations of dexamethasone-ondansetron and dexamethasone-ondansetron-aprepitant versus aprepitant alone for early postoperative nausea and vomiting after day care gynaecological laparoscopy: a randomised clinical trial.","volume":"65","author":"Thanuja","year":"2021","journal-title":"Indian J Anaesth"},{"key":"R19-20260710","first-page":"362","article-title":"Antiemetic efficacy of combined aprepitant and dexamethasone in patients at high-risk of postoperative nausea and vomiting from epidural fentanyl analgesia.","volume":"81","author":"Kawano","year":"2015","journal-title":"Minerva Anestesiol"},{"key":"R20-20260710","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s11695-013-1065-1","article-title":"Aprepitant\u2019s prophylactic efficacy in decreasing postoperative nausea and vomiting in morbidly obese patients undergoing bariatric surgery.","volume":"24","author":"Sinha","year":"2014","journal-title":"Obes Surg"},{"key":"R21-20260710","doi-asserted-by":"crossref","first-page":"212","DOI":"10.4097\/kjae.2013.64.3.212","article-title":"Efficacy of the oral neurokinin-1 receptor antagonist aprepitant administered with ondansetron for the prevention of postoperative nausea and vomiting.","volume":"64","author":"Lim","year":"2013","journal-title":"Korean J Anesthesiol"},{"key":"R22-20260710","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/1745-6215-13-130","article-title":"Aprepitant versus ondansetron in preoperative triple-therapy treatment of nausea and vomiting in neurosurgery patients: study protocol for a randomized controlled trial.","volume":"13","author":"Bergese","year":"2012","journal-title":"Trials"},{"key":"R23-20260710","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1007\/s00540-012-1529-9","article-title":"Oral administration of aprepitant to prevent postoperative nausea in highly susceptible patients after gynecological laparoscopy.","volume":"27","author":"Jung","year":"2013","journal-title":"J Anesth"},{"key":"R24-20260710","doi-asserted-by":"crossref","first-page":"221","DOI":"10.4097\/kjae.2012.63.3.221","article-title":"The effect of aprepitant for the prevention of postoperative nausea and vomiting in patients undergoing gynecologic surgery with intravenous patient controlled analgesia using fentanyl: aprepitant plus ramosetron vs ramosetron alone.","volume":"63","author":"Lee","year":"2012","journal-title":"Korean J Anesthesiol"},{"key":"R25-20260710","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1213\/ANE.0b013e3181ff47e2","article-title":"A comparison of the combination of aprepitant and dexamethasone versus the combination of ondansetron and dexamethasone for the prevention of postoperative nausea and vomiting in patients undergoing craniotomy.","volume":"112","author":"Habib","year":"2011","journal-title":"Anesth Analg"},{"key":"R26-20260710","doi-asserted-by":"crossref","first-page":"246","DOI":"10.2152\/jmi.58.246","article-title":"Neurokinin-1 receptor antagonism, aprepitant, effectively diminishes post-operative nausea and vomiting while increasing analgesic tolerance in laparoscopic gynecological procedures.","volume":"58","author":"Kakuta","year":"2011","journal-title":"J Med Invest"},{"key":"R27-20260710","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1093\/bja\/aem133","article-title":"Single-dose aprepitant vs ondansetron for the prevention of postoperative nausea and vomiting: a randomized, double-blind phase III trial in patients undergoing open abdominal surgery.","volume":"99","author":"Diemunsch","year":"2007","journal-title":"Br J Anaesth"},{"key":"R28-20260710","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1185\/030079907X233115","article-title":"Preventing postoperative nausea and vomiting: post hoc analysis of pooled data from two randomized active-controlled trials of aprepitant.","volume":"23","author":"Diemunsch","year":"2007","journal-title":"Curr Med Res Opin"},{"key":"R29-20260710","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1213\/01.ane.0000263277.35140.a3","article-title":"A randomized, double-blind comparison of the NK1 antagonist, aprepitant, versus ondansetron for the prevention of postoperative nausea and vomiting.","volume":"104","author":"Gan","year":"2007","journal-title":"Anesth Analg"},{"key":"R30-20260710","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1016\/j.neuropharm.2008.07.016","article-title":"Serotonin and GI clinical disorders.","volume":"55","author":"Spiller","year":"2008","journal-title":"Neuropharmacology"},{"key":"R31-20260710","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.bbadis.2011.03.016","article-title":"Intestinal mast cells in gut inflammation and motility disturbances.","volume":"1822","author":"De Winter","year":"2012","journal-title":"Biochim Biophys Acta"},{"key":"R32-20260710","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1254\/jphs.91.87","article-title":"Roles of substance P and NK(1) receptor in the brainstem in the development of emesis.","volume":"91","author":"Saito","year":"2003","journal-title":"J Pharmacol Sci"},{"key":"R33-20260710","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.brainres.2008.03.077","article-title":"Utilization of the least shrew as a rapid and selective screening model for the antiemetic potential and brain penetration of substance P and NK1 receptor antagonists.","volume":"1214","author":"Darmani","year":"2008","journal-title":"Brain Res"},{"key":"R34-20260710","first-page":"2952","article-title":"Behavioral and electrophysiological studies of peptide-induced emesis in dogs.","volume":"43","author":"Carpenter","year":"1984","journal-title":"Fed Proc"},{"key":"R35-20260710","doi-asserted-by":"crossref","first-page":"3158","DOI":"10.1021\/cr900117p","article-title":"Evidence for a re-evaluation of the neurochemical and anatomical bases of chemotherapy-induced vomiting.","volume":"109","author":"Darmani","year":"2009","journal-title":"Chem Rev"},{"key":"R36-20260710","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.ejphar.2013.10.037","article-title":"Pathophysiological and neurochemical mechanisms of postoperative nausea and vomiting.","volume":"722","author":"Horn","year":"2014","journal-title":"Eur J Pharmacol"},{"key":"R37-20260710","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/0166-4328(84)90220-1","article-title":"Peptide-induced emesis in dogs.","volume":"11","author":"Carpenter","year":"1984","journal-title":"Behav Brain Res"},{"key":"R38-20260710","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/0361-9230(93)90112-O","article-title":"Behavioral studies of emetic sensitivity in the ferret.","volume":"31","author":"Knox","year":"1993","journal-title":"Brain Res Bull"},{"key":"R39-20260710","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/BF03020521","article-title":"Apfel\u2019s simplified score may favourably predict the risk of postoperative nausea and vomiting.","volume":"49","author":"Pierre","year":"2002","journal-title":"Can J Anaesth"},{"key":"R40-20260710","doi-asserted-by":"crossref","first-page":"e762","DOI":"10.1097\/MD.0000000000000762","article-title":"Neurokinin-1 receptor antagonists in preventing postoperative nausea and vomiting: a systematic review and meta-analysis.","volume":"94","author":"Liu","year":"2015","journal-title":"Medicine (Baltim)"},{"key":"R41-20260710","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1136\/postgradmedj-2015-133515","article-title":"Aprepitant for postoperative nausea and vomiting: a systematic review and meta-analysis.","volume":"92","author":"Singh","year":"2016","journal-title":"Postgrad Med J"},{"key":"R42-20260710","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.2165\/11203680-000000000-00000","article-title":"Aprepitant: a review of its use in the prevention of nausea and vomiting.","volume":"69","author":"Curran","year":"2009","journal-title":"Drugs"},{"key":"R43-20260710","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1093\/bja\/aes276","article-title":"Evidence-based analysis of risk factors for postoperative nausea and vomiting.","volume":"109","author":"Apfel","year":"2012","journal-title":"Br J Anaesth"},{"key":"R44-20260710","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1111\/jgs.15767","article-title":"American geriatrics society 2019 updated AGS beers criteria\u00ae for potentially inappropriate medication use in older adults.","volume":"67","year":"2019","journal-title":"J Am Geriatr Soc"},{"key":"R45-20260710","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1213\/01.ane.0000239223.74552.0a","article-title":"The additive interactions between ondansetron and droperidol for preventing postoperative nausea and vomiting.","volume":"103","author":"Chan","year":"2006","journal-title":"Anesth Analg"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000034385","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T00:00:13Z","timestamp":1783728013000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000034385"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,21]]},"references-count":45,"journal-issue":{"issue":"29","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000034385","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7,21]]}}}